MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

CRBU — Caribou Biosciences, Inc. Common Stock

Nasdaq

Caribou Biosciences, Inc. Common Stock

CompareBack to Screener
$1.22
+0.00(+0.00%)
O
1.24
H
1.24
L
1.22
V
866.36K
⏱️ End-of-day dataAs of Oct 2, 2026

CRBU — Financial Statements

Historical 2-Year Statements
Financial Metric / Line ItemQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Fiscal Date2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Periodquarterlyquarterlyquarterlyquarterlyquarterlyquarterly
Year2,026.002,025.002,025.002,025.002,025.002,024.00
Cash And Cash Equivalents12,057.0012,360.0011,144.0025,201.0029,417.0016,293.00
Other Short Term Investments105,569.00126,980.00136,115.00158,747.00179,048.00193,244.00
Accounts Receivable227.0069.00242.0071.0088.00265.00
Other Receivables2,136.002,910.002,688.002,709.002,652.002,056.00
Prepaid Assets2,392.002,913.001,927.003,060.003,855.004,808.00
Total Current Assets122,381.00145,232.00155,506.00192,506.00217,323.00219,377.00
Properties33,005.0033,306.0031,885.0032,294.0038,977.0039,063.00
Machinery Furniture Equipment1,594.001,594.001,594.001,594.001,594.001,594.00
Leases3,057.003,057.003,016.003,016.0011,518.0011,518.00
Accumulated Depreciation-14,177.00-13,527.00-12,893.00-12,264.00-14,050.00-12,885.00
Investments And Advances1,001.003,505.0012,096.00132.0013,252.0049,125.00
Other Non Current Assets2,137.002,200.003,780.003,625.005,042.005,521.00
Total Non Current Assets26,617.0030,135.0039,478.0028,397.0056,333.0093,936.00
Total Assets148,998.00175,367.00194,984.00220,903.00273,656.00313,313.00
Accounts Payable3,503.005,783.003,804.003,243.003,873.002,476.00
Accrued Expenses9,445.007,974.0010,977.0013,215.0013,826.0013,399.00
Short Term Debt1,287.001,201.002,687.002,287.001,901.001,426.00
Deferred Revenue994.001,895.002,217.002,829.002,829.003,129.00
Pensions3,712.007,745.006,515.005,240.004,518.008,560.00
Other Current Liabilities732.00816.001,858.002,073.001,544.001,661.00
Total Current Liabilities19,673.0025,414.0028,058.0028,887.0028,491.0030,651.00
Long Term Debt25,659.0026,026.0022,777.0023,564.0024,323.0025,061.00
Total Non Current Liabilities27,307.0027,778.0025,081.0025,884.0027,943.0029,711.00
Total Liabilities46,980.0053,192.0053,139.0054,771.0056,434.0060,362.00
Common Stock10.009.009.009.009.009.00
Retained Earnings-621,600.00-596,515.00-570,027.00-542,479.00-488,381.00-448,390.00
Other Shareholders Equity-23.00103.0093.0040.00167.00255.00
Total Shareholders Equity102,018.00122,175.00141,845.00166,132.00217,222.00252,951.00
Additional Paid In Capital723,631.00718,578.00711,770.00708,562.00705,427.00701,077.00
Cash EquivalentsN/A12,360.00N/AN/AN/A16,293.00
Deferred LiabilitiesN/A0.00548.00548.00548.00548.00
Other Current AssetsN/AN/A3,390.002,718.002,263.001,781.00
Other Non Current LiabilitiesN/AN/AN/AN/A451.00785.00
Construction In ProgressN/AN/AN/AN/AN/A0.00